HB 1089

1
A bill to be entitled
2An act relating to health care initiatives; creating s.
3460.4062, F.S.; authorizing the Department of Health to
4issue a chiropractic medicine faculty certificate for
5certain faculty who have accepted appointment at a
6publicly funded state university or college; authorizing
7an application fee; providing requirements; providing for
8renewal and expiration of the certificate; creating s.
91004.383, F.S.; authorizing a chiropractic medicine degree
10program at Florida State University; amending s. 561.121,
11F.S.; providing for annual appropriations from the
12proceeds of the excise tax on alcoholic beverages;
13providing for distribution of the funds to the Department
14of Elderly Affairs, the Department of Health, and Florida
15State University for specified research and programs;
16amending s. 1004.43, F.S.; authorizing the establishment
17of for-profit subsidiaries of the governing corporation of
18the H. Lee Moffitt Cancer Center and Research Institute;
19prohibiting certain activities by such for-profit
20subsidiaries; requiring that the contract with the State
21Board of Education permit the use of lands, facilities,
22and personnel for research, education, treatment,
23prevention, and early detection of cancer; authorizing the
24governing corporation and its subsidiaries to obtain their
25own property insurance coverage; requiring that certain
26appropriations be paid directly to the board of directors
27of the governing corporation; changing the appointing
28authority for certain members of the council of scientific
29advisers; amending s. 1004.445, F.S.; renaming the Florida
30Alzheimer's Center and Research Institute as the Johnnie
31B. Byrd, Sr., Alzheimer's Center and Research Institute;
32deleting obsolete provisions; authorizing the
33establishment of for-profit subsidiaries of the governing
34corporation; requiring that the contract with the State
35Board of Education permit the use of lands, facilities,
36and personnel for research, education, treatment,
37prevention, and early detection of Alzheimer's disease;
38authorizing the governing corporation and its subsidiaries
39to obtain their own property insurance coverage; requiring
40that certain appropriations be paid directly to the board
41of directors of the governing corporation; changing the
42appointing authority for certain members of the council of
43scientific advisers; creating the Florida Center for
44Universal Research to Eradicate Disease within the
45Department of Health; providing legislative findings and
46intent; specifying the purpose and duties of the center;
47requiring an annual report to the Governor and
48Legislature; authorizing the department to outsource the
49duties of the center; creating an advisory council;
50amending s. 215.5602, F.S.; expanding the long-term goals
51of the James and Esther King Biomedical Research Program
52to include the cure of specified diseases; providing
53funding priority; amending s. 215.5601, F.S., relating to
54the Lawton Chiles Endowment Fund, to conform an intent
55provision; designating the Life Sciences Building at
56Florida State University as the "James E. 'Jim' King, Jr.,
57Building"; authorizing Florida State University to erect
58markers; creating the Florida Cancer Council; providing
59for the affairs of the council; requiring an annual
60report; specifying the council's mission and duties;
61creating the Florida Public Health Foundation, Inc.;
62providing for the foundation's duties and mission;
63providing for its board of directors; requiring annual
64reports; requiring the foundation to coordinate monthly
65health awareness campaigns to disseminate information
66about specified diseases and conditions; establishing the
67Prostate Cancer Awareness Program within the Department of
68Health for the purpose of providing statewide outreach and
69education concerning the early detection of prostate
70cancer; authorizing the department and the Florida Public
71Health Foundation, Inc., to enter into contracts and seek
72grant moneys; creating an advisory committee to assist the
73program; providing for membership of the committee;
74authorizing reimbursement for certain per diem and travel
75expenses; creating the Cervical Cancer Elimination Task
76Force; providing duties and membership of the task force;
77requiring the task force to make periodic reports to the
78Governor and the Legislature; providing for the task force
79to be dissolved on a specified date; providing an
80effective date.
81
82
83Be It Enacted by the Legislature of the State of Florida:
84
85     Section 1.  Section 460.4062, Florida Statutes, is created
86to read:
87     460.4062  Chiropractic medicine faculty certificate.--
88     (1)  The department may issue a chiropractic medicine
89faculty certificate without examination to an individual who
90remits a nonrefundable application fee, not to exceed $100 as
91determined by rule of the board, and who demonstrates to the
92board that he or she meets the following requirements:
93     (a)  Is a graduate of an accredited school or college of
94chiropractic accredited by the Council on Chiropractic
95Education.
96     (b)  Holds a valid current license to practice chiropractic
97medicine in another jurisdiction in the United States.
98     (c)  Is at least 21 years of age and of good moral
99character.
100     (d)  Has not committed any act or offense in any
101jurisdiction which would constitute the basis for discipline
102under this chapter or chapter 456.
103     (e)  Has been offered and has accepted a full-time faculty
104appointment to teach in a program of chiropractic medicine at a
105publicly funded state university or college and provides a
106certification from the dean of the appointing college
107acknowledging the appointment.
108     (2)  The certificate shall authorize the holder to practice
109only in conjunction with his or her faculty position at a
110publicly funded state university or college and its affiliated
111clinics that are registered with the board as sites at which
112holders of chiropractic medicine faculty certificates will be
113practicing. Such certificate shall automatically expire upon
114termination of the holder's relationship with the school or
115after a period of 2 years, whichever occurs first.
116     (3)  The holder of a faculty certificate may engage in the
117practice of chiropractic medicine as permitted by this section.
118     (4)  Notwithstanding subsection (2), a chiropractic
119medicine faculty certificate is renewable every 2 years by a
120holder who applies to the board on a form prescribed by the
121board and who continues to satisfy the requirements set forth in
122subsection (1).
123     Section 2.  Section 1004.383, Florida Statutes, is created
124to read:
125     1004.383  Chiropractic medicine degree program at Florida
126State University.--A chiropractic medicine degree program is
127authorized at Florida State University.
128     Section 3.  Paragraph (a) of subsection (1) of section
129561.121, Florida Statutes, is amended to read:
130     561.121  Deposit of revenue.--
131     (1)  All state funds collected pursuant to ss. 563.05,
132564.06, and 565.12 shall be paid into the State Treasury and
133disbursed in the following manner:
134     (a)1.  Two percent of monthly collections of the excise
135taxes on alcoholic beverages established in ss. 563.05, 564.06,
136and 565.12 shall be deposited into the Alcoholic Beverage and
137Tobacco Trust Fund to meet the division's appropriation for the
138state fiscal year.
139     2.  Beginning July 1, 2004, there is annually distributed
140$15 million to the Grants and Donations Trust Fund within the
141Department of Elderly Affairs, and these funds are annually
142appropriated to support a contract with the Johnnie B. Byrd,
143Sr., Alzheimer's Center and Research Institute at the University
144of South Florida for the purposes of conducting research,
145developing and operating integrated data projects, and providing
146assistance to memory disorder clinics as established in s.
147430.502.
148     3.  Beginning July 1, 2004, there is annually distributed
149$6 million to the Biomedical Research Trust Fund within the
150Department of Health, and these funds are annually appropriated
151to the James and Esther King Biomedical Research Program. From
152these funds, up to $250,000 shall be available annually for the
153operating costs of the Florida Center for Universal Research to
154Eradicate Disease.
155     4.  Beginning July 1, 2004, there is annually distributed
156$9 million to be paid by warrant drawn by the Chief Financial
157Officer upon the State Treasury to Florida State University for
158the School of Chiropractic Medicine. Notwithstanding the
159provisions of chapter 216, until the School of Chiropractic
160Medicine is completely staffed and fully operational, these
161funds may be used for any purpose by the university.
162     Section 4.  Section 1004.43, Florida Statutes, is amended
163to read:
164     1004.43  H. Lee Moffitt Cancer Center and Research
165Institute.--There is established the H. Lee Moffitt Cancer
166Center and Research Institute at the University of South
167Florida.
168     (1)  The State Board of Education shall enter into an
169agreement for the utilization of the facilities on the campus of
170the University of South Florida to be known as the H. Lee
171Moffitt Cancer Center and Research Institute, including all
172furnishings, equipment, and other chattels used in the operation
173of said facilities, with a Florida not-for-profit corporation
174organized solely for the purpose of governing and operating the
175H. Lee Moffitt Cancer Center and Research Institute. This not-
176for-profit corporation, acting as an instrumentality of the
177State of Florida, shall govern and operate the H. Lee Moffitt
178Cancer Center and Research Institute in accordance with the
179terms of the agreement between the State Board of Education and
180the not-for-profit corporation. The not-for-profit corporation
181may, with the prior approval of the State Board of Education,
182create either for-profit or not-for-profit corporate
183subsidiaries, or both, to fulfill its mission. For-profit
184subsidiaries of the not-for-profit corporation may not compete
185with for-profit health care providers in the delivery of
186radiation therapy services to patients. The not-for-profit
187corporation and its subsidiaries are authorized to receive,
188hold, invest, and administer property and any moneys received
189from private, local, state, and federal sources, as well as
190technical and professional income generated or derived from
191practice activities of the institute, for the benefit of the
192institute and the fulfillment of its mission. The affairs of the
193corporation shall be managed by a board of directors who shall
194serve without compensation. The President of the University of
195South Florida and the chair of the State Board of Education, or
196his or her designee, shall be directors of the not-for-profit
197corporation, together with 5 representatives of the state
198universities and no more than 14 nor fewer than 10 directors who
199are not medical doctors or state employees. Each director shall
200have only one vote, shall serve a term of 3 years, and may be
201reelected to the board. Other than the President of the
202University of South Florida and the chair of the State Board of
203Education, directors shall be elected by a majority vote of the
204board. The chair of the board of directors shall be selected by
205majority vote of the directors.
206     (2)  The State Board of Education shall provide in the
207agreement with the not-for-profit corporation for the following:
208     (a)  Approval of the articles of incorporation of the not-
209for-profit corporation by the State Board of Education.
210     (b)  Approval of the articles of incorporation of any not-
211for-profit corporate subsidiary created by the not-for-profit
212corporation.
213     (c)  Utilization of lands, hospital facilities, and
214personnel by the not-for-profit corporation and its subsidiaries
215for research, education, treatment, prevention, and the early
216detection of cancer and for mutually approved teaching and
217research programs conducted by the University of South Florida
218or other accredited medical schools or research institutes.
219     (d)  Preparation of an annual financial audit of the not-
220for-profit corporation's accounts and records and the accounts
221and records of any subsidiaries to be conducted by an
222independent certified public accountant. The annual audit report
223shall include a management letter, as defined in s. 11.45, and
224shall be submitted to the Auditor General and the State Board of
225Education. The State Board of Education, the Auditor General,
226and the Office of Program Policy Analysis and Government
227Accountability shall have the authority to require and receive
228from the not-for-profit corporation and any subsidiaries or from
229their independent auditor any detail or supplemental data
230relative to the operation of the not-for-profit corporation or
231subsidiary.
232     (e)  Provision by the not-for-profit corporation and its
233subsidiaries of equal employment opportunities to all persons
234regardless of race, color, religion, sex, age, or national
235origin.
236     (3)  The State Board of Education is authorized to secure
237comprehensive general liability protection, including
238professional liability protection, for the not-for-profit
239corporation and its subsidiaries pursuant to s. 1004.24. The
240not-for-profit corporation and its subsidiaries shall be exempt
241from any participation in any property insurance trust fund
242established by law, including any property insurance trust fund
243established pursuant to chapter 284, so long as the not-for-
244profit corporation and its subsidiaries maintain property
245insurance protection with comparable or greater coverage limits.
246     (4)  In the event that the agreement between the not-for-
247profit corporation and the State Board of Education is
248terminated for any reason, the State Board of Education shall
249resume governance and operation of said facilities.
250     (5)  The institute shall be administered by a chief
251executive officer who shall serve at the pleasure of the board
252of directors of the not-for-profit corporation and who shall
253have the following powers and duties subject to the approval of
254the board of directors:
255     (a)  The chief executive officer shall establish programs
256which fulfill the mission of the institute in research,
257education, treatment, prevention, and the early detection of
258cancer; however, the chief executive officer shall not establish
259academic programs for which academic credit is awarded and which
260terminate in the conference of a degree without prior approval
261of the State Board of Education.
262     (b)  The chief executive officer shall have control over
263the budget and the dollars appropriated or donated to the
264institute from private, local, state, and federal sources, as
265well as technical and professional income generated or derived
266from practice activities of the institute. However, professional
267income generated by university faculty from practice activities
268at the institute shall be shared between the institute and the
269university as determined by the chief executive officer and the
270appropriate university dean or vice president.
271     (c)  The chief executive officer shall appoint members to
272carry out the research, patient care, and educational activities
273of the institute and determine compensation, benefits, and terms
274of service. Members of the institute shall be eligible to hold
275concurrent appointments at affiliated academic institutions.
276University faculty shall be eligible to hold concurrent
277appointments at the institute.
278     (d)  The chief executive officer shall have control over
279the use and assignment of space and equipment within the
280facilities.
281     (e)  The chief executive officer shall have the power to
282create the administrative structure necessary to carry out the
283mission of the institute.
284     (f)  The chief executive officer shall have a reporting
285relationship to the Commissioner of Education.
286     (g)  The chief executive officer shall provide a copy of
287the institute's annual report to the Governor and Cabinet, the
288President of the Senate, the Speaker of the House of
289Representatives, and the chair of the State Board of Education.
290     (6)  The board of directors of the not-for-profit
291corporation shall create a council of scientific advisers to the
292chief executive officer comprised of leading researchers,
293physicians, and scientists. This council shall review programs
294and recommend research priorities and initiatives so as to
295maximize the state's investment in the institute. The council
296shall be appointed by the board of directors of the not-for-
297profit corporation and shall include five appointees of the
298State Board of Education. Each member of the council shall be
299appointed to serve a 2-year term and may be reappointed to the
300council.
301     (7)  In carrying out the provisions of this section, the
302not-for-profit corporation and its subsidiaries are not
303"agencies" within the meaning of s. 20.03(11).
304     (8)(a)  Records of the not-for-profit corporation and of
305its subsidiaries are public records unless made confidential or
306exempt by law.
307     (b)  Proprietary confidential business information is
308confidential and exempt from the provisions of s. 119.07(1) and
309s. 24(a), Art. I of the State Constitution. However, the Auditor
310General, the Office of Program Policy Analysis and Government
311Accountability, and the State Board of Education, pursuant to
312their oversight and auditing functions, must be given access to
313all proprietary confidential business information upon request
314and without subpoena and must maintain the confidentiality of
315information so received. As used in this paragraph, the term
316"proprietary confidential business information" means
317information, regardless of its form or characteristics, which is
318owned or controlled by the not-for-profit corporation or its
319subsidiaries; is intended to be and is treated by the not-for-
320profit corporation or its subsidiaries as private and the
321disclosure of which would harm the business operations of the
322not-for-profit corporation or its subsidiaries; has not been
323intentionally disclosed by the corporation or its subsidiaries
324unless pursuant to law, an order of a court or administrative
325body, a legislative proceeding pursuant to s. 5, Art. III of the
326State Constitution, or a private agreement that provides that
327the information may be released to the public; and which is
328information concerning:
329     1.  Internal auditing controls and reports of internal
330auditors;
331     2.  Matters reasonably encompassed in privileged attorney-
332client communications;
333     3.  Contracts for managed-care arrangements, including
334preferred provider organization contracts, health maintenance
335organization contracts, and exclusive provider organization
336contracts, and any documents directly relating to the
337negotiation, performance, and implementation of any such
338contracts for managed-care arrangements;
339     4.  Bids or other contractual data, banking records, and
340credit agreements the disclosure of which would impair the
341efforts of the not-for-profit corporation or its subsidiaries to
342contract for goods or services on favorable terms;
343     5.  Information relating to private contractual data, the
344disclosure of which would impair the competitive interest of the
345provider of the information;
346     6.  Corporate officer and employee personnel information;
347     7.  Information relating to the proceedings and records of
348credentialing panels and committees and of the governing board
349of the not-for-profit corporation or its subsidiaries relating
350to credentialing;
351     8.  Minutes of meetings of the governing board of the not-
352for-profit corporation and its subsidiaries, except minutes of
353meetings open to the public pursuant to subsection (9);
354     9.  Information that reveals plans for marketing services
355that the corporation or its subsidiaries reasonably expect to be
356provided by competitors;
357     10.  Trade secrets as defined in s. 688.002, including
358reimbursement methodologies or rates; or
359     11.  The identity of donors or prospective donors of
360property who wish to remain anonymous or any information
361identifying such donors or prospective donors. The anonymity of
362these donors or prospective donors must be maintained in the
363auditor's report.
364
365As used in this paragraph, the term "managed care" means systems
366or techniques generally used by third-party payors or their
367agents to affect access to and control payment for health care
368services. Managed-care techniques most often include one or more
369of the following: prior, concurrent, and retrospective review of
370the medical necessity and appropriateness of services or site of
371services; contracts with selected health care providers;
372financial incentives or disincentives related to the use of
373specific providers, services, or service sites; controlled
374access to and coordination of services by a case manager; and
375payor efforts to identify treatment alternatives and modify
376benefit restrictions for high-cost patient care.
377     (9)  Meetings of the governing board of the not-for-profit
378corporation and meetings of the subsidiaries of the not-for-
379profit corporation at which the expenditure of dollars
380appropriated to the not-for-profit corporation by the state are
381discussed or reported must remain open to the public in
382accordance with s. 286.011 and s. 24(b), Art. I of the State
383Constitution, unless made confidential or exempt by law. Other
384meetings of the governing board of the not-for-profit
385corporation and of the subsidiaries of the not-for-profit
386corporation are exempt from s. 286.011 and s. 24(b), Art. I of
387the State Constitution.
388     (10)  In addition to the continuing appropriation to the
389institute provided in s. 210.20(2), any appropriation to the
390institute provided in a general appropriations act shall be paid
391directly to the board of directors of the not-for-profit
392corporation by warrant drawn by the Chief Financial Officer from
393the State Treasury.
394     Section 5.  Section 1004.445, Florida Statutes, is amended
395to read:
396     1004.445  Johnnie B. Byrd, Sr., Florida Alzheimer's Center
397and Research Institute.--
398     (1)  Effective July 1, 2002, The Johnnie B. Byrd, Sr.,
399Florida Alzheimer's Center and Research Institute is established
400at the University of South Florida.
401     (2)(a)  The State Board of Education shall enter into an
402agreement for the utilization of the facilities on the campus of
403the University of South Florida to be known as the Johnnie B.
404Byrd, Sr., Florida Alzheimer's Center and Research Institute,
405including all furnishings, equipment, and other chattels used in
406the operation of those facilities, with a Florida not-for-profit
407corporation organized solely for the purpose of governing and
408operating the Johnnie B. Byrd, Sr., Florida Alzheimer's Center
409and Research Institute. This not-for-profit corporation, acting
410as an instrumentality of the state, shall govern and operate the
411Johnnie B. Byrd, Sr., Florida Alzheimer's Center and Research
412Institute in accordance with the terms of the agreement between
413the State Board of Education and the not-for-profit corporation.
414The not-for-profit corporation may, with the prior approval of
415the State Board of Education, create either for-profit or not-
416for-profit corporate subsidiaries, or both, to fulfill its
417mission. The not-for-profit corporation and its subsidiaries are
418authorized to receive, hold, invest, and administer property and
419any moneys acquired from private, local, state, and federal
420sources, as well as technical and professional income generated
421or derived from practice activities of the institute, for the
422benefit of the institute and the fulfillment of its mission.
423     (b)1.  The affairs of the not-for-profit corporation shall
424be managed by a board of directors who shall serve without
425compensation. The board of directors shall consist of the
426President of the University of South Florida and the chair of
427the State Board of Education, or their designees, 5
428representatives of the state universities, and no fewer than 9
429nor more than 14 representatives of the public who are neither
430medical doctors nor state employees. Each director who is a
431representative of a state university or of the public shall be
432appointed to serve a term of 3 years. The chair of the board of
433directors shall be selected by a majority vote of the directors.
434Each director shall have only one vote.
435     2.  The initial board of directors shall consist of the
436President of the University of South Florida and the chair of
437the State Board of Education, or their designees; the five
438university representatives, of whom one shall be appointed by
439the Governor, two by the President of the Senate, and two by the
440Speaker of the House of Representatives; and nine public
441representatives, of whom three shall be appointed by the
442Governor, three by the President of the Senate, and three by the
443Speaker of the House of Representatives. Upon the expiration of
444the terms of the initial appointed directors, all directors
445subject to 3-year terms of office under this paragraph shall be
446appointed by a majority vote of the directors and the board may
447be expanded to include additional public representative
448directors up to the maximum number allowed. Any vacancy in
449office shall be filled for the remainder of the term by majority
450vote of the directors. Any director may be reappointed.
451     (3)  The State Board of Education shall provide in the
452agreement with the not-for-profit corporation for the following:
453     (a)  Approval by the State Board of Education of the
454articles of incorporation of the not-for-profit corporation.
455     (b)  Approval by the State Board of Education of the
456articles of incorporation of any not-for-profit corporate
457subsidiary created by the not-for-profit corporation.
458     (c)  Utilization of lands, hospital facilities, and
459personnel by the not-for-profit corporation and its subsidiaries
460for research, education, treatment, prevention, and the early
461detection of Alzheimer's disease and for mutually approved
462teaching and research programs conducted by the University of
463South Florida or other accredited medical schools or research
464institutes.
465     (d)  Preparation of an annual postaudit of the not-for-
466profit corporation's financial accounts and the financial
467accounts of any subsidiaries to be conducted by an independent
468certified public accountant. The annual audit report shall
469include management letters and shall be submitted to the Auditor
470General and the State Board of Education for review. The State
471Board of Education, the Auditor General, and the Office of
472Program Policy Analysis and Government Accountability shall have
473the authority to require and receive from the not-for-profit
474corporation and any subsidiaries, or from their independent
475auditor, any detail or supplemental data relative to the
476operation of the not-for-profit corporation or subsidiary.
477     (e)  Provision by the not-for-profit corporation and its
478subsidiaries of equal employment opportunities for all persons
479regardless of race, color, religion, gender, age, or national
480origin.
481     (4)  The State Board of Education is authorized to secure
482comprehensive general liability protection, including
483professional liability protection, for the not-for-profit
484corporation and its subsidiaries, pursuant to s. 1004.24. The
485not-for-profit corporation and its subsidiaries shall be exempt
486from any participation in any property insurance trust fund
487established by law, including any property insurance trust fund
488established pursuant to chapter 284, so long as the not-for-
489profit corporation and its subsidiaries maintain property
490insurance protection with comparable or greater coverage limits.
491     (5)  In the event that the agreement between the not-for-
492profit corporation and the State Board of Education is
493terminated for any reason, the State Board of Education shall
494assume governance and operation of the facilities.
495     (6)  The institute shall be administered by a chief
496executive officer, who shall be appointed by and serve at the
497pleasure of the board of directors of the not-for-profit
498corporation, and who shall exercise the following powers and
499duties, subject to the approval of the board of directors:
500     (a)  The chief executive officer shall establish programs
501that fulfill the mission of the institute in research,
502education, treatment, prevention, and early detection of
503Alzheimer's disease; however, the chief executive officer may
504not establish academic programs for which academic credit is
505awarded and which culminate in the conferring of a degree,
506without prior approval of the State Board of Education.
507     (b)  The chief executive officer shall have control over
508the budget and the moneys appropriated or donated to the
509institute from private, local, state, and federal sources, as
510well as technical and professional income generated or derived
511from practice activities of the institute. However, professional
512income generated by university faculty from practice activities
513at the institute shall be shared between the institute and the
514university as determined by the chief executive officer and the
515appropriate university dean or vice president.
516     (c)  The chief executive officer shall appoint
517representatives of the institute to carry out the research,
518patient care, and educational activities of the institute and
519establish the compensation, benefits, and terms of service of
520such representatives. Representatives of the institute shall be
521eligible to hold concurrent appointments at affiliated academic
522institutions. University faculty shall be eligible to hold
523concurrent appointments at the institute.
524     (d)  The chief executive officer shall have control over
525the use and assignment of space and equipment within the
526facilities.
527     (e)  The chief executive officer shall have the power to
528create the administrative structure necessary to carry out the
529mission of the institute.
530     (f)  The chief executive officer shall have a reporting
531relationship to the Commissioner of Education.
532     (g)  The chief executive officer shall provide a copy of
533the institute's annual report to the Governor and Cabinet, the
534President of the Senate, the Speaker of the House of
535Representatives, and the chair of the State Board of Education.
536     (7)  The board of directors of the not-for-profit
537corporation shall create a council of scientific advisers to the
538chief executive officer comprised of leading researchers,
539physicians, and scientists. The council shall review programs
540and recommend research priorities and initiatives to maximize
541the state's investment in the institute. The members of the
542council shall be appointed by the board of directors of the not-
543for-profit corporation, except for five members who shall be
544appointed by the State Board of Education. Each member of the
545council shall be appointed to serve a 2-year term and may be
546reappointed to the council.
547     (8)  In carrying out the provisions of this section, the
548not-for-profit corporation and its subsidiaries are not agencies
549within the meaning of s. 20.03(11).
550     (9)  The following information is confidential and exempt
551from the provisions of s. 119.07(1) and s. 24, Art. I of the
552State Constitution:
553     (a)  Personal identifying information relating to clients
554of programs created or funded through the Johnnie B. Byrd, Sr.,
555Florida Alzheimer's Center and Research Institute which is held
556by the institute, University of South Florida, or State Board of
557Education or by persons who provide services to clients of
558programs created or funded through contracts with the Johnnie B.
559Byrd, Sr., Florida Alzheimer's Center and Research Institute;
560     (b)  Any medical or health records relating to patients
561which may be created or received by the institute;
562     (c)  Materials that relate to methods of manufacture or
563production, potential trade secrets, potentially patentable
564material, actual trade secrets as defined in s. 688.002, or
565proprietary information received, generated, ascertained, or
566discovered during the course of research conducted by or through
567the institute and business transactions resulting from such
568research;
569     (d)  The identity of a donor or prospective donor to the
570Johnnie B. Byrd, Sr., Florida Alzheimer's Center and Research
571Institute who wishes to remain anonymous, and all information
572identifying such donor or prospective donor;
573     (e)  Any information received by the institute in the
574performance of its duties and responsibilities which is
575otherwise confidential and exempt by law; and
576     (f)  Any information received by the institute from a
577person from another state or nation or the Federal Government
578which is otherwise confidential or exempt pursuant to that
579state's or nation's laws or pursuant to federal law.
580
581Any governmental entity that demonstrates a need to access such
582confidential and exempt information in order to perform its
583duties and responsibilities shall have access to such
584information and shall otherwise keep such information
585confidential and exempt. This section is subject to the Open
586Government Sunset Review Act of 1995 in accordance with s.
587119.15 and shall stand repealed on October 2, 2006, unless
588reviewed and saved from repeal through reenactment by the
589Legislature.
590     (10)  Any appropriation to the institute provided in a
591general appropriations act shall be paid directly to the board
592of directors of the not-for-profit corporation by warrant drawn
593by the Chief Financial Officer from the State Treasury.
594     Section 6.  Florida Center for Universal Research to
595Eradicate Disease.--
596     (1)  The Legislature finds that an estimated 128 million
597Americans suffer from acute, chronic, and degenerative diseases
598and that biomedical research is the key to finding cures for
599these diseases that negatively affect all Floridians. The
600Legislature further finds that, while there is much research
601being conducted throughout this state and throughout the world,
602there is a lack of coordination of efforts among researchers.
603The Legislature, therefore, finds that there is a significant
604need for a coordinated effort if the goal of curing disease is
605to be achieved. Moreover, the Legislature finds that the
606biomedical technology sector meets the criteria of a high-impact
607sector, pursuant to section 288.108, Florida Statutes, having a
608high importance to this state's economy with a significant
609potential for growth and contribution to our universities and
610quality of life.
611     (2)  It is the intent of the Legislature that Florida
612strive to become the nation's leader in biomedical research and
613commit itself to being the state to find cures for the most
614deadly and widespread diseases. It is further the intent of the
615Legislature that there be a coordinated effort among the state's
616public and private universities and the biomedical industry to
617discover such cures. Moreover, it is the intent of the
618Legislature to expand the state economy by attracting biomedical
619researchers and research companies to this state.
620     (3)  There is established within the Department of Health
621the Florida Center for Universal Research to Eradicate Disease,
622which shall be known as "CURED."
623     (a)  The purpose of the center is to coordinate, improve,
624expand, and monitor all biomedical research programs within the
625state, facilitate funding opportunities, and foster improved
626technology transfer of research findings into clinical trials
627and widespread public use.
628     (b)  The goal of the center is to find cures for diseases
629such as cancer, heart disease, lung disease, diabetes,
630autoimmune disorders, and neurological disorders, including
631Alzheimer's disease, epilepsy, and Parkinson's disease.
632     (c)  The center shall hold an annual biomedical technology
633summit in Florida to which biomedical researchers, biomedical
634technology companies, business incubators, pharmaceutical
635manufacturers, and others around the nation and world are
636invited to share biomedical research findings in order to
637expedite the discovery of cures. Summit attendees shall cover
638the costs of such attendance or obtain sponsorship for such
639attendance.
640     (d)  The center shall encourage clinical trials in this
641state on research that holds promise of curing a disease or
642condition. The center shall facilitate partnerships between
643researchers, treating physicians, and community hospitals for
644the purpose of sharing new techniques and new research findings,
645as well as coordinating voluntary donations to ensure an
646adequate supply of adult stem cells, placentas, or cord blood.
647     (e)  The center shall facilitate the formation of
648partnerships between researchers in this state and institutions
649in other states and countries where research with rare plants or
650animals could lead to cures.
651     (f)  The center shall encourage agricultural colleges and
652agricultural businesses in this state to be active in the search
653for cures and in providing information to the public about
654disease prevention.
655     (g)  The center shall facilitate partnerships among
656researchers working to cure all types of diseases, including
657those that are prevalent in developed countries and those that
658occur mainly in developing countries.
659     (h)  The center shall also encourage the discovery and
660production in Florida of vaccines that prevent disease.
661     (i)  The center shall monitor the supply and demand needs
662of researchers relating to stem cell research and other types of
663human tissue research. If the center determines that there is a
664need for increased donation of human tissue, it shall notify
665hospitals licensed pursuant to chapter 395, Florida Statutes,
666which have entered into partnership agreements with research
667institutes conducting stem cell research located in the same
668geographic region as the researchers demanding the stem cells or
669other tissues. Such hospitals shall implement programs that
670encourage voluntary donations of cord blood or other needed
671adult tissue.
672     (j)  The center shall be funded through private, state, and
673federal sources.
674     (k)  The center shall serve as a registry of all known
675opportunities for biomedical grants and may assist any public or
676private biomedical research program in this state in preparing
677grant requests.
678     (l)  The center shall maintain a website with links to
679peer-reviewed biomedical research. The website shall also
680contain a list of all known biomedical research being conducted
681in Florida and shall facilitate communication among researchers
682and other interested parties.
683     (m)  The center shall submit an annual report to the
684Governor, the President of the Senate, and the Speaker of the
685House of Representatives no later than January 15 which contains
686recommendations for legislative change necessary to foster a
687positive climate for biomedical research in this state.
688     (4)  The Department of Health may outsource the duties of
689the center to a private entity or state university.
690     (5)  There is established within the center an advisory
691council that shall meet at least annually.
692     (a)  The council shall consist of the members of the board
693of directors of the Florida Research Consortium and at least one
694representative from:
695     1.  The Emerging Technology Commission.
696     2.  Enterprise Florida, Inc.
697     3.  BioFlorida.
698     4.  The Biomedical Research Advisory Council.
699     5.  The Florida Medical Foundation.
700     6.  Pharmaceutical Research and Manufacturers of America.
701     7.  The Florida Tri-Agency Coalition on Smoking OR Health.
702     Remove line(s) 706-1100 and insert:
703     8.  The Florida Cancer Council.
704     9.  The American Cancer Society, Florida Division, Inc.
705     10.  The American Heart Association.
706     11.  The American Lung Association of Florida.
707     12.  The American Diabetes Association, South Coastal
708Region.
709     13.  The Alzheimer's Association.
710     14.  The Epilepsy Foundation.
711     15.  The National Parkinson Foundation.
712     16.  The Florida Public Health Foundation, Inc.
713     17.  Scripps Florida or the entity formed in this state by
714The Scripps Research Institute.
715     (b)  Members of the council shall serve without
716compensation and each organization represented shall cover all
717expenses of its representative.
718     Section 7.  Paragraph (d) of subsection (1) of section
719215.5601, Florida Statutes, is amended to read:
720     215.5601  Lawton Chiles Endowment Fund.--
721     (1)  LEGISLATIVE INTENT.--It is the intent of the
722Legislature to:
723     (d)  Provide funds to help support public-health and
724biomedical research for the prevention, diagnosis, and
725treatment, and cure of diseases related to tobacco use by
726creating an annual and perpetual source of funding for
727biomedical research in the state in order to expand the
728foundation of biomedical knowledge relating to the prevention,
729diagnosis, and treatment, and cure of diseases related to
730tobacco use, including cancer, cardiovascular disease, stroke,
731and pulmonary disease; improve the quality of the state's
732academic health centers by bringing the advances of biomedical
733research into the training of physicians and other health care
734providers; and increase the state's per capita funding for
735biomedical research by undertaking new initiatives in biomedical
736research which will attract additional funding from outside the
737state while also stimulating economic activity in the state in
738areas related to biomedical research, such as the research and
739production of pharmaceuticals, biotechnology, and medical
740devices.
741     Section 8.  Paragraphs (a) and (b) of subsection (1) and
742subsections (2) and (10) of section 215.5602, Florida Statutes,
743are amended to read:
744     215.5602  James and Esther King Biomedical Research
745Program.--
746     (1)  There is established within the Department of Health
747the James and Esther King Biomedical Research Program funded by
748the proceeds of the Lawton Chiles Endowment Fund pursuant to s.
749215.5601. The purpose of the James and Esther King Biomedical
750Research Program is to provide an annual and perpetual source of
751funding in order to support research initiatives that address
752the health care problems of Floridians in the areas of tobacco-
753related cancer, cardiovascular disease, stroke, and pulmonary
754disease. The long-term goals of the program are to:
755     (a)  Improve the health of Floridians by researching better
756prevention, diagnoses, and treatments, and cures for cancer,
757cardiovascular disease, stroke, and pulmonary disease.
758     (b)  Expand the foundation of biomedical knowledge relating
759to the prevention, diagnosis, and treatment, and cure of
760diseases related to tobacco use, including cancer,
761cardiovascular disease, stroke, and pulmonary disease.
762     (2)  Funds appropriated for the James and Esther King
763Biomedical Research Program shall be used exclusively for the
764award of grants and fellowships as established in this section;
765for research relating to the prevention, diagnosis, and
766treatment, and cure of diseases related to tobacco use,
767including cancer, cardiovascular disease, stroke, and pulmonary
768disease; and for expenses incurred in the administration of this
769section. Priority shall be granted to research designed to
770prevent or cure disease.
771     (10)  The council shall submit an annual progress report on
772the state of biomedical research in this state to the Florida
773Center for Universal Research to Eradicate Disease and to the
774Governor, the Secretary of Health, the President of the Senate,
775and the Speaker of the House of Representatives by February 1.
776The report must include:
777     (a)  A list of research projects supported by grants or
778fellowships awarded under the program.
779     (b)  A list of recipients of program grants or fellowships.
780     (c)  A list of publications in peer reviewed journals
781involving research supported by grants or fellowships awarded
782under the program.
783     (d)  The total amount of biomedical research funding
784currently flowing into the state.
785     (e)  New grants for biomedical research which were funded
786based on research supported by grants or fellowships awarded
787under the program.
788     (f)  Progress in the prevention, diagnosis, and treatment,
789and cure of diseases related to tobacco use, including cancer,
790cardiovascular disease, stroke, and pulmonary disease.
791     Section 9.  (1)  The Life Sciences Building at Florida
792State University in Tallahassee is designated as the "James E.
793'Jim' King, Jr., Building."
794     (2)  Florida State University is authorized to erect
795markers for the designation of the James E. "Jim" King, Jr.,
796Building as described in subsection (1).
797     Section 10.  Florida Cancer Council.--
798     (1)  Effective July 1, 2004, the Florida Cancer Council
799within the Department of Health is established for the purpose
800of making the state a center of excellence for cancer research.
801     (2)(a)  The council shall be representative of the state's
802cancer centers, hospitals, and patient groups, and shall be
803organized and shall operate in accordance with this act.
804     (b)  The Florida Cancer Council may create not-for-profit
805corporate subsidiaries to fulfill its mission. The council and
806its subsidiaries are authorized to receive, hold, invest, and
807administer property and any moneys acquired from private, local,
808state, and federal sources, as well as technical and
809professional income generated or derived from the mission-
810related activities of the council.
811     (c)  The members of the council shall consist of:
812     1.  Chairman of the Florida Dialogue on Cancer, who shall
813serve as the chairman of the council;
814     2.  Secretary of the Department of Health or his or her
815designee;
816     3.  Chief Executive Officer of the H. Lee Moffitt Cancer
817Center or his or her designee;
818     4.  Director of the University of Florida Shands Cancer
819Center or his or her designee;
820     5.  Chief Executive Officer of the University of Miami
821Sylvester Comprehensive Cancer Center or his or her designee;
822     6.  Chief Executive Officer of the Mayo Clinic,
823Jacksonville or his or her designee;
824     7.  Chief Executive Officer of the American Cancer Society,
825Florida Division or his or her designee;
826     8.  President of the American Cancer Society, Florida
827Division Board of Directors or his or her designee;
828     9.  President of the Florida Society of Clinical Oncology
829or his or her designee;
830     10.  President of the American College of Surgeons, Florida
831Chapter, or his or her designee;
832     11.  Chief Executive Officer of Enterprise Florida, Inc.,
833or his or her designee;
834     12.  Five representatives from cancer programs approved by
835the American College of Surgeons. Three shall be appointed by
836the Governor, one shall be appointed by the Speaker of the House
837of Representatives, and one shall be appointed by the President
838of the Senate;
839     13.  One member of the House of Representatives, to be
840appointed by the Speaker of the House of Representatives; and
841     14.  One member of the Senate, to be appointed by the
842President of the Senate.
843     (d)  Appointments made by the Speaker of the House of
844Representatives and the President of the Senate pursuant to
845paragraph (c) shall be for 2-year terms, concurrent with the
846bienniums in which they serve as presiding officers.
847     (e)  Appointments made by the Governor pursuant to
848paragraph (c) shall be for 2-year terms, although the Governor
849may reappoint members.
850     (f)  Members of the council or any subsidiaries shall serve
851without compensation, and each organization represented on the
852council shall cover the expenses of its representatives.
853     (3)  The council shall issue an annual report to the Center
854for Universal Research to Eradicate Disease, the Governor, the
855Speaker of the House of Representatives, and the President of
856the Senate by December 15 of each year, with policy and funding
857recommendations regarding cancer research capacity in Florida
858and related issues.
859     Section 11.  Florida Cancer Council, mission and
860duties.--The council, which shall work in concert with the
861Florida Center for Universal Research to Eradicate Disease to
862ensure that the goals of the center are advanced, shall endeavor
863to dramatically improve cancer research and treatment in this
864state through:
865     (1)  Efforts to significantly expand cancer research
866capacity in the state by:
867     (a)  Identifying ways to attract new research talent and
868attendant national grant producing researchers to Florida-based
869cancer research facilities;
870     (b)  Implementing a peer-reviewed, competitive process to
871identify and fund the best proposals to expand cancer research
872institutes in this state;
873     (c)  Funding through available resources for those
874proposals that demonstrate the greatest opportunity to attract
875federal research grants and private financial support;
876     (d)  Encouraging the employment of bioinformatics in order
877to create a cancer informatics infrastructure that enhances
878information and resource exchange and integration through
879researchers working in diverse disciplines, to facilitate the
880full spectrum of cancer investigations;
881     (e)  Facilitating the technical coordination, business
882development, and support of intellectual property as it relates
883to the advancement of cancer research; and
884     (f)  Aiding in other multidisciplinary research-support
885activities as they inure to the advancement of cancer research.
886     (2)  Efforts to improve both research and treatment through
887greater participation in clinical trials networks by:
888     (a)  Identifying ways to increase adult enrollment in
889cancer clinical trials;
890     (b)  Supporting public and private professional education
891programs designed to increase the awareness and knowledge about
892cancer clinical trials;
893     (c)  Providing tools to cancer patients and community-based
894oncologists to aid in the identification of cancer clinical
895trials available in the state; and
896     (d)  Creating opportunities for the state's academic cancer
897centers to collaborate with community-based oncologists in
898cancer clinical trials networks.
899     (3)  Efforts to reduce the impact of cancer on disparate
900groups by:
901     (a)  Identifying those cancers that disproportionately
902impact certain demographic groups; and
903     (b)  Building collaborations designed to reduce health
904disparities as they relate to cancer.
905     Section 12.  The Florida Public Health Foundation, Inc.;
906establishment; purpose; mission; duties; board of directors.--
907     (1)  The Florida Public Health Foundation, Inc., referred
908to in this section as "the corporation," is established for the
909purpose of disseminating breakthrough findings in biomedical
910research and promoting health awareness in this state.
911     (2)  The corporation's mission includes disseminating
912information about innovative biomedical research and clinical
913trials in this state as well as making Floridians and their
914treatment providers aware of specified diseases and conditions
915and available methods of preventing, diagnosing, treating, and
916curing those diseases and conditions.
917     (3)  The purpose and objective of the corporation shall be
918to operate exclusively for charitable, scientific, and
919educational purposes; to protect and improve the health and
920well-being of Florida's people and environment through
921partnerships committed to program innovation, education, applied
922research, and policy development; and to engage in charitable
923programs dedicated to improving the health of Floridians.
924     (4)  The corporation shall be established as a not-for-
925profit entity qualifying under section 501(c)(3) of the Internal
926Revenue Code. The corporation may receive, hold, invest, and
927administer property and any moneys acquired from private, local,
928state, and federal sources, as well as technical and
929professional income generated or derived from the mission-
930related activities of the corporation. The corporation shall
931have all of the powers conferred upon corporations organized
932under chapter 617, Florida Statutes.
933     (5)  The corporation's duties include procuring funds
934necessary for accomplishing the purpose and mission of the
935corporation. The corporation shall strive to complement,
936supplement, and enhance the missions of the various
937organizations, entities, and departments represented on its
938board by serving as the lead corporation in the state for
939promoting public health awareness.
940     (6)  The affairs of the corporation shall be managed by an
941executive director appointed by a board of directors consisting
942of:
943     (a)  The Secretary of Health or his or her designee.
944     (b)  A former member of the Senate appointed by the
945President of the Senate.
946     (c)  A former member of the House of Representatives
947appointed by the Speaker of the House of Representatives.
948     (d)  A representative of the American Heart Association.
949     (e)  A representative of the American Cancer Society,
950Florida Division, Inc.
951     (f)  A representative of the American Lung Association of
952Florida.
953     (g)  A representative of the American Diabetes Association,
954South Coastal Region.
955     (h)  A representative of the Alzheimer's Association.
956     (i)  A representative of the Epilepsy Foundation.
957     (j)  A representative of the National Parkinson Foundation.
958     (k)  A representative of the March of Dimes, Florida
959Chapter.
960     (l)  A representative of the Arthritis Foundation, Florida
961Chapter.
962     (m)  A representative of the American Liver Foundation.
963     (n)  A representative of the Florida Council for Behavioral
964Healthcare, Inc.
965     (o)  A representative of the Florida Alcohol and Drug Abuse
966Association.
967     (p)  A representative of Pharmaceutical Research and
968Manufacturers of America.
969     (q)  A representative of the Florida Public Health
970Association.
971     (r)  A representative of the Florida Association of County
972Health Officers.
973     (s)  A public health academician selected by the State
974Health Officer.
975     (t)  A representative of the Florida Academy of Family
976Physicians.
977     (u)  Three consumers who have demonstrated an interest in
978protecting the public health appointed by the Florida Public
979Health Association.
980     (7)  Members of the board of directors shall serve for 2-
981year terms and shall serve without compensation. Each
982organization represented on the board of directors shall cover
983the expenses of its representative.
984     (8)  The corporation, in consultation with the Department
985of Health and the Florida Center for Universal Research to
986Eradicate Disease, shall facilitate communication between
987biomedical researchers and health care providers each month
988according to the health awareness schedule established by the
989Florida Public Health Foundation, Inc., in order to ensure
990ongoing dialogue between researchers, treatment providers, and
991the department.
992     (9)  The corporation and the Department of Health shall
993enter into partnerships with providers of continuing education
994for health care practitioners, including, but not limited to,
995hospitals and state and local medical organizations, to ensure
996that practitioners are aware of the most recent and complete
997diagnostic and treatment tools.
998     (10)  The corporation shall provide an annual report
999concerning its activities and finances to the Florida Center for
1000Universal Research to Eradicate Disease and shall provide copies
1001of the annual report to the Governor, the President of the
1002Senate, and the Speaker of the House of Representatives.
1003     Section 13.  Health awareness campaigns.--
1004     (1)  The Florida Public Health Foundation, Inc., in
1005consultation with the Department of Health, shall coordinate
1006monthly health awareness campaigns with national, state, and
1007local health care organizations and government entities
1008targeting a wide range of the public, including: parents;
1009teachers and other school employees; students in 4th through
101012th grades, colleges, and universities; state agency employees;
1011county and local government employees; patients of county health
1012departments; Medicaid recipients; health care professionals and
1013providers; and the public in general.
1014     (2)  The awareness campaigns shall include the provision of
1015educational information about preventing, detecting, treating,
1016and curing the following diseases or conditions. Additional
1017diseases and conditions that impact the public health may be
1018added by the board of directors of the Florida Public Health
1019Foundation, Inc.; however, each of the following diseases or
1020conditions must be included in an awareness campaign during at
1021least one month in any 24-month period:
1022     (a)  Cancer, including breast, prostate, cervical, ovarian,
1023colorectal, and skin cancer and leukemia.
1024     (b)  Heart disease.
1025     (c)  Stroke.
1026     (d)  Lung disease, including asthma and smoking-relating
1027disease.
1028     (e)  Neurological disorders and disease, including
1029Alzheimer's disease, Parkinson's disease, and epilepsy.
1030     (f)  Gastrointestinal disease.
1031     (g)  Kidney disease.
1032     (h)  Diabetes.
1033     (i)  Liver disease.
1034     (j)  Autoimmune disorders.
1035     (k)  Birth defects and prenatal care.
1036     (l)  Obesity and malnutrition.
1037     (m)  Sexually transmissible disease.
1038     (n)  Hepatitis A, hepatitis B, and hepatitis C.
1039     (o)  Arthritis.
1040     (p)  Vaccine-preventable diseases.
1041     (q)  Infectious diseases, including HIV/AIDS.
1042     (r)  Substance abuse.
1043     (s)  Mental illness.
1044     (t)  Lupus.
1045     (u)  Osteoporosis.
1046     (3)  The health awareness campaigns shall be funded by the
1047Florida Public Health Foundation, Inc., and the Department of
1048Health to the extent that funds are available from public and
1049private sources.
1050     (4)  Health awareness information shall be disseminated
1051through all available methods, including print, audio, visual,
1052and electronic media.
1053     Section 14.  Prostate Cancer Awareness Program.--
1054     (1)  To the extent that funds are specifically made
1055available for this purpose, the Prostate Cancer Awareness
1056Program is established within the Department of Health. The
1057purpose of this program is to implement the recommendations of
1058January 2000 of the Florida Prostate Cancer Task Force to
1059provide for statewide outreach and health education activities
1060to ensure that men are aware of and appropriately seek medical
1061counseling for prostate cancer as an early-detection health care
1062measure.
1063     (2)  For purposes of implementing the program, the
1064Department of Health and the Florida Public Health Foundation,
1065Inc., may:
1066     (a)  Conduct activities directly or enter into a contract
1067with a qualified nonprofit community education entity.
1068     (b)  Seek any available gifts, grants, or funds from the
1069state, the Federal Government, philanthropic foundations, and
1070industry or business groups.
1071     (3)  A prostate cancer advisory committee is created to
1072advise and assist the Department of Health and the Florida
1073Public Health Foundation, Inc., in implementing the program.
1074     (a)  The Secretary of Health shall appoint the advisory
1075committee members, who shall consist of:
1076     1.  Three persons from prostate cancer survivor groups or
1077cancer-related advocacy groups.
1078     2.  Three persons who are scientists or clinicians from
1079public universities or research organizations.
1080     3.  Three persons who are engaged in the practice of a
1081cancer-related medical specialty from health organizations
1082committed to cancer research and control.
1083     (b)  Members shall serve without compensation but are
1084entitled to reimbursement, pursuant to section 112.061, Florida
1085Statutes, for per diem and travel expenses incurred in the
1086performance of their official duties.
1087     (4)  The program shall coordinate its efforts with those of
1088the Florida Public Health Foundation, Inc.
1089     Section 15.  Cervical Cancer Elimination Task Force.--
1090     (1)  Effective July 1, 2004, the Cervical Cancer
1091Elimination Task Force is established for the purpose of
1092recommending strategies and actions to reduce the costs and
1093burdens of cervical cancer in Florida. The task force shall
1094present interim reports to the Florida Public Health Foundation,
1095Inc., the Florida Cancer Council, the Center for Universal
1096Research to Eradicate Disease, the Governor, the President of
1097the Senate, and the Speaker of the House of Representatives on
1098January 1, 2006, and July 1, 2007, with a final report due on
1099June 30, 2008. After submitting its final report on or before
1100June 30, 2008, the task force is dissolved.
1101     (2)  The task force shall:
1102     (a)  Review statistical and qualitative data on the
1103prevalence and burden of cervical cancer.
1104     (b)  Receive and consider reports and testimony from
1105individuals, county health departments, community-based
1106organizations, and other public and private organizations
1107statewide to learn more about their contributions to cervical
1108cancer diagnosis, prevention, and treatment, as well as their
1109ideas for improving the care of cervical cancer patients in this
1110state.
1111     (c)  Identify priority strategies and new technologies,
1112including newly introduced vaccines, which are effective in
1113preventing and controlling the risk of cervical cancer.
1114     (d)  Provide recommendations to the Florida Public Health
1115Foundation, Inc., on public awareness issues relating to
1116cervical cancer, such as the causes, personal risk factors,
1117value of prevention, available vaccines, early detection
1118options, treatment costs, new technology, and education for
1119health care practitioners.
1120     (e)  Identify and examine existing programs, services,
1121laws, and rules regarding the availability and coverage of
1122treatment services for cervical cancer.
1123     (f)  Develop and revise a comprehensive Florida Cervical
1124Cancer Prevention Plan and present those recommendations to the
1125Department of Health and the Florida Cancer Control and Research
1126Advisory Council for incorporation into the Florida Cancer Plan.
1127     (3)  The task force shall consist of:
1128     (a)  The director of the Department of Health's Division of
1129Disease Control or another person with expertise in epidemiology
1130who shall serve as chair, appointed by the Secretary of Health.
1131     (b)  A board-certified gynecologist licensed as a physician
1132under chapter 458 or chapter 459, Florida Statutes, representing
1133the Florida Obstetric and Gynecologic Society, appointed by the
1134Governor.
1135     (c)  A family physician licensed under chapter 458 or
1136chapter 459, Florida Statutes, who provides gynecology services
1137representing the Florida Academy of Family Physicians, appointed
1138by the Governor.
1139     (d)  An oncologist licensed as a physician under chapter
1140458 or chapter 459, Florida Statutes, representing the Florida
1141Division of the American Cancer Society, appointed by the
1142President of the Senate.
1143     (e)  An advanced registered nurse practitioner who
1144practices gynecology representing the Florida Nurses
1145Association, appointed by the Speaker of the House of
1146Representatives.
1147     (f)  A member of the Legislative Women's Caucus, appointed
1148by the President of the Senate.
1149     (g)  A member of the Legislative Women's Caucus, appointed
1150by the Speaker of the House of Representatives.
1151     (h)  The chief executive officer of the H. Lee Moffitt
1152Cancer Center and Research Institute or his or her designee.
1153     (i)  The director of the University of Florida Shands
1154Cancer Center or his or her designee.
1155     (j)  The director of the University of Miami Sylvester
1156Comprehensive Cancer Center or his or her designee.
1157     (k)  The chief executive officer of the Mayo Clinic,
1158Jacksonville, or his or her designee.
1159     (4)  Members of the task force shall be appointed to 4-year
1160terms without compensation, and each organization represented
1161shall cover the expenses of its representative.
1162     Section 16.  Except as otherwise expressly provided in this
1163act, this act shall take effect upon becoming a law.


CODING: Words stricken are deletions; words underlined are additions.